Search
for
Sort by
Research 30 of 37
- Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor
- Effection of Epristeride and Finasteride on Spermatogenesis in Male Rats
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- Identification of Metabolites for the Novel 5α‐Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing
- ChemInform Abstract: Discovery of a Novel Hybrid from Finasteride and Epristeride as 5α‐Reductase Inhibitor.
- An overview on 5α-reductase inhibitors
- Chapter 23. Therapeutic Control of Androgen Action
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Market Analysis of 5α-Reductase Inhibitor
- Screen steroid 5 alpha-reductase inhibitors in vitro by high performance liquid chromatography
- New Synthesis of Methyl 3β-Hydroxy-5-androstene-17β-carboxylate
- Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Evaluation of 5α-reductase inhibitory activity of certain herbs useful as antiandrogens
- Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells
- Abietic Acid from Resina Pini of Pinus Species as a Testosterone 5.ALPHA.-Reductase Inhibitor
- Novel inhibitors of 5α-reductase
- Geranylated Coumarins From Thai Medicinal Plant Mammea siamensis With Testosterone 5α-Reductase Inhibitory Activity
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- Clinical use of 5α-reductase inhibitors
- Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Exploring the Potential of Eclipta alba: A Promising Approach for Hair Treatment Management through 5-Alpha Reductase Inhibition
- The utilisation of cardiac risk ratio and non-HDL cholesterol markers to assess cardiovascular risk in type 2 diabetes males with lowered serum DHT
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors